2022
DOI: 10.1038/s41467-022-28438-x
|View full text |Cite
|
Sign up to set email alerts
|

Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression

Abstract: The formation of pre-metastatic niche is a key step in the metastatic burden. The pluripotent factor Lin28B is frequently expressed in breast tumors and is particularly upregulated in the triple negative breast cancer subtype. Here, we demonstrate that Lin28B promotes lung metastasis of breast cancer by building an immune-suppressive pre-metastatic niche. Lin28B enables neutrophil recruitment and N2 conversion. The N2 neutrophils are then essential for immune suppression in pre-metastatic lung by PD-L2 up-regu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
66
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(66 citation statements)
references
References 55 publications
0
66
0
Order By: Relevance
“…Lin28, an RNA-binding protein, is one of the master regulators of embryonic stem cell self-renewal that correlates with clinical tumor grade and the terminal metastasis of breast cancer [ 50 ]. In the MMTV-PyMT mouse model, Lin28B did not affect the primary tumor growth but promoted the development of lung metastases [ 54 ], suggesting that the ability of cancer cells to self-renew can promote distant metastasis in breast cancer. IL-6 secreted from differentiated cancer cells supports CSC survival, metastasis, and treatment resistance in breast cancer [ 55 , 56 ].…”
Section: Emt In Metastatic Breast Cancermentioning
confidence: 99%
“…Lin28, an RNA-binding protein, is one of the master regulators of embryonic stem cell self-renewal that correlates with clinical tumor grade and the terminal metastasis of breast cancer [ 50 ]. In the MMTV-PyMT mouse model, Lin28B did not affect the primary tumor growth but promoted the development of lung metastases [ 54 ], suggesting that the ability of cancer cells to self-renew can promote distant metastasis in breast cancer. IL-6 secreted from differentiated cancer cells supports CSC survival, metastasis, and treatment resistance in breast cancer [ 55 , 56 ].…”
Section: Emt In Metastatic Breast Cancermentioning
confidence: 99%
“…By suppressing the local immunity, tumor-derived exosomes can distantly support the colonization of the pre-metastatic site. Let-7 downregulation due to its binding by Lin28 allowed the building of an immune-suppressive pre-metastatic niche in the lungs, by enabling neutrophil recruitment and N2 conversion in vivo [ 87 ]. Let-7 restoration in exosomes was able to abolish the immunosuppressive and pro-metastatic effects of breast cancer cell-derived exosomes, highlighting its extensive inhibitory role in tumor progression [ 87 , 88 ].…”
Section: Perspectives Of Exosomal Mirnas From Preclinical Modelsmentioning
confidence: 99%
“…Let-7 downregulation due to its binding by Lin28 allowed the building of an immune-suppressive pre-metastatic niche in the lungs, by enabling neutrophil recruitment and N2 conversion in vivo [ 87 ]. Let-7 restoration in exosomes was able to abolish the immunosuppressive and pro-metastatic effects of breast cancer cell-derived exosomes, highlighting its extensive inhibitory role in tumor progression [ 87 , 88 ]. Another important factor in the development of the pre-metastatic niche is the metabolic reprogramming of the resident cells.…”
Section: Perspectives Of Exosomal Mirnas From Preclinical Modelsmentioning
confidence: 99%
“…Frontiers in Cell and Developmental Biology frontiersin.org Dormant cancer cells are characterized by increased p38 mitogen-activated protein kinase (p38 MAPK) and decreased extracellular signal-regulated kinase 1/2 (ERK1/2) activity; the p38 MAPK high /ERK low phenotype is commonly used as a marker of dormancy (Recasens and Munoz, 2019).…”
Section: Tans and Persistent Growth Dormancy And Recurrence Of Tumor ...mentioning
confidence: 99%